Innova Biosciences Appoints Steve Howell as Non-Executive Director
News Feb 03, 2016
Innova Biosciences (Innova) has announced the appointment of Professor Steve Howell to the Board of Directors.
Steve has over 20 years of experience building and growing life science enterprises, including founding life science investment company Innova Partnerships in 2006. Prior to this he was Director of Business Development at Alere Inc, and Research Director at Unipath Ltd, after joining Unilever Plc.
He is visiting Professor of Commercial Innovation at Kings College London and also advises the Scottish and Irish governments on high growth businesses and life science strategy.
Tim Bernard, Chairman of the Board at Innova Biosciences, commented: “We are delighted to welcome Steve to the Board of Directors. His knowledge and experience will be a valuable addition to the company as we continue to expand.”
Professor Howell said: “Innova Biosciences’ world leading bioconjugation technology business is backed by a team of dedicated executives, scientists and customer service personnel. I am very pleased to be joining the Board, to help lead Innova through its next stages of development.”
Absolute Antibody and Kerafast Merge Increasing Access to Unique Reagents and Recombinant Antibody TechnologyNews
Absolute Antibody Ltd., and Kerafast Inc., have announced a merger of the two companies. The merger brings together two companies with a shared commitment to improving the selection of research tools available to the scientific community.READ MORE
Lonza to Establish Cell- and Gene-Therapy Centers of Excellence to Accelerate GrowthNews
Lonza will establish Centers of Excellence for Cell and Gene Therapy to support and accelerate the growth of this priority area for the company.READ MORE
Comments | 0 ADD COMMENT
3rd Annual Bioprocessing of Advanced Cellular Therapies
May 29 - May 30, 2018